Patient‐specific risk factors for MG exacerbation and hospitalisation include disease onset after the age of 50 years (late‐onset MG [LOMG]), comorbidities, previous MC, Abs against muscle‐specific kinase (MuSK), thymoma and severe disease at diagnosis [14, 15, 16]. This evidence concerns the gene MUSK and myasthenia gravis.